Alpha lipoic acid (Ala) for the treatment of diabetic neuropathy
Diabetes is a condition of life must be treated and lifestyle change and ongoing monitoring. Diabetic patients in the long run, no matter which of the two main types of diabetes, living with. Both type 1 and type 2 diabetes is associated with increased blood glucose and the inability of cells to take sugar from the energy needed for the tasks they must perform every day.
All forms of diabetes provide anserious problem to face the risk of a heart attack, stroke, eye disease and kidney failure. One of the difficulties in the long term effects of most diabetes, diabetic neuropathy, involving changes in the peripheral nerves associated with sensation of pins and needles and loss of sensation in hands and feet.
The alpha lipoic acid (ALA) found in the liver, potatoes and broccoli, and has been prescribed for diabetic neuropathy in Germany. ALA has no effectlevels of glucose in the blood is promoted to the neuropathy of diabetes. In a three-week study of 328 German patients with type 2 diabetes and diabetic neuropathy patients received a placebo intravenously or ALA. The study had statistically significant results in improving the symptoms of pain, itching, and disability-related neuropathy in those with ALA. The study also examined 73 patients with type 2 diabetes and cardiovascular neuropathy who had taken oral ALAplacebo – was an improvement in the action of a conduction abnormalities in those with heart palpitations ALA.
In an attempt to repeat intravenous ALA these promising results, a second multi-center study of 509 patients with diabetic neuropathy three weeks, followed by six months oral ALA or placebo. This time there were no statistically significant differences in ALA compared with placebo in changes in general symptoms. The same group also examined 120 patientsthree weeks intravenously or placebo using ALA and had a statistically significant change in symptoms. Thus, even if it appears that ALA is some benefit from the results of studies vary, and it is not clear that a lasting benefit for diabetic neuropathy.